Evidence map›Paper›PMID 25978849›Full record

ArticleJournal of neuropathology and experimental neurology2015

Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.

Anna Nogalska, Carla D'Agostino, W King Engel, Mafalda Cacciottolo, Shinichi Asada, Kazutoshi Mori, Valerie Askanas

Open access · greenAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The role of amyloid β in the pathological mechanism of GNE myopathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Inclusion Body Myositis: Update on Pathogenesis and Treatment.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
    Review
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Anna NogalskaFrom the USC Neuromuscular Center, Department of Neurology, University of Southern California Keck School of Medicine, Good Samaritan Hospital, Los Angeles, California (AN, CDA, WKE, MC, VA); and Department of Biophysics, Graduate School of Science, Kyoto University, Kyoto, Japan (SA, KM).
Carla D'Agostino
W King Engel
Mafalda Cacciottolo
Shinichi Asada
Kazutoshi Mori
Valerie Askanas
University of Southern California · USGood Samaritan Hospital · USKyoto University · JP

Funding

ALZHEIMER-LIKE PATHOLOGY IN INCLUSION BODY MYOPATHYR37AG016768 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ASKANAS, VALERIE · 1999 to 2005
$1.9M
NIA NIH HHS AG16768NIA NIH HHS R37 AG016768
6 · The paper itself

Abstract

Muscle fibers in patients with sporadic inclusion-body myositis (s-IBM),the most common age-associated myopathy, are characterized by autophagic vacuoles and accumulation of ubiquitinated and congophilic multiprotein aggregates that contain amyloid-β and phosphorylated tau. Muscle fibers of autosomal-recessive hereditary inclusion-body myopathy caused by the GNE mutation (GNE-h-IBM) display similar pathologic features, except with less pronounced congophilia. Accumulation of unfolded/misfolded proteins inside the endoplasmic reticulum (ER) lumen leads to ER stress, which elicits the unfolded protein response (UPR) as a protective mechanism. Here we demonstrate for the first time that UPR is activated in s-IBM muscle biopsies, since there was 1) increased activating transcription factor 4 (ATF4) protein and increased mRNA of its target C/EBP homologous protein; 2) cleavage of the ATF6 and increased mRNA of its target glucose-regulated protein 78; and 3) an increase of the spliced form of X-box binding protein 1 and increased mRNA of ER degradation-enhancing α-mannosidase-like protein, target of heterodimer of cleaved ATF6 and spliced X-box binding protein 1. In contrast, we did not find similar evidence of the UPR induction in GNE-h-IBM patient muscle, suggesting that different intracellular mechanisms might lead to similar pathologic phenotypes. Interestingly, cultured GNE-h-IBM muscle fibers had a robust UPR response to experimental ER stress stimuli, suggesting that the GNE mutation per se is not responsible for the lack of UPR in GNE-h-IBM biopsied muscle.

Indexed as

Activating Transcription Factor 4Activating Transcription Factor 6AgedCadherinsCells, CulturedDistal MyopathiesDNA-Binding ProteinsEndoplasmic Reticulum Chaperone BiPEnzyme InhibitorsFemaleHeat-Shock ProteinsHumansMaleMiddle AgedMultienzyme ComplexesMuscle Fibers, SkeletalActivating Transcription Factor 4Activating Transcription Factor 6ATF4 protein, humanATF6 protein, humanCadherinsDNA-Binding ProteinsEndoplasmic Reticulum Chaperone BiPEnzyme InhibitorsHeat-Shock ProteinsMultienzyme ComplexesRegulatory Factor X Transcription FactorsRNA, MessengerTranscription FactorsUDP-N-acetylglucosamine 2-epimerase - N-acetylmannosamine kinase

Identifiers

PMID25978849
PMCPMC4506930
OpenAlexW277734681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.